ProfileGDS5678 / 1429179_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 20% 21% 21% 20% 22% 29% 20% 21% 20% 20% 20% 20% 20% 20% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.5133720
GSM967853U87-EV human glioblastoma xenograft - Control 22.4892121
GSM967854U87-EV human glioblastoma xenograft - Control 32.4895321
GSM967855U87-EV human glioblastoma xenograft - Control 42.4254620
GSM967856U87-EV human glioblastoma xenograft - Control 52.4719422
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.7248129
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.506920
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4730721
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4581820
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4623420
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4744620
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4503820
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4843420
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4727620